Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

greymattermom

(5,797 posts)
14. That's so interesting to me
Thu Jan 20, 2022, 08:57 AM
Jan 2022

I was doing some research years ago funded by Merck on their version of the drug, telcagepant, which did not make it though phase 3 because of some liver enzyme issues. The drug worked in our research model, but Merck quit working on it. I'm glad to see that it's back. It's an oral CGRP inhibitor.

Recommendations

0 members have recommended this reply (displayed in chronological order):

Latest Discussions»Support Forums»Chronic Health Conditions Discussion and Support»Has anyone tried the new ...»Reply #14